A systematic review and meta-analysis considering the SSRI, SNRI and TCA classes of antidepressants and the risk for congenital heart defects

Courtney De Vries, Svetla Gadzhanova, Matthew J. Sykes, Michael Ward, Elizabeth Roughead
doi: https://doi.org/10.1101/2020.02.24.20027532

Article Information

doi 
https://doi.org/10.1101/2020.02.24.20027532
History 
  • February 27, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Courtney De Vries*,
  2. Svetla Gadzhanova,
  3. Matthew J. Sykes,
  4. Michael Ward and
  5. Elizabeth Roughead
  1. University of South Australia, School of Pharmacy and Medical Sciences
  2. University of South Australia, Quality Use of Medicines and Pharmacy Research Centre
  1. ↵*Corresponding author; email: devce002{at}mymail.unisa.edu.au
Back to top
Posted February 27, 2020.
Download PDF

Supplementary Material

Data/Code
Email
A systematic review and meta-analysis considering the SSRI, SNRI and TCA classes of antidepressants and the risk for congenital heart defects
Courtney De Vries, Svetla Gadzhanova, Matthew J. Sykes, Michael Ward, Elizabeth Roughead
medRxiv 2020.02.24.20027532; doi: https://doi.org/10.1101/2020.02.24.20027532
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area